Published: Jun 7, 2026
Written by Klarity Editorial Team
Published: Jun 7, 2026

If you’re struggling with binge eating disorder (BED), you’re not alone—and getting help may be easier than you think. Thanks to expanded telehealth regulations, millions of Americans can now access medication and professional support for BED entirely online, without ever setting foot in a doctor’s office.
But can you really get prescription medication for binge eating disorder through a video call? What about controlled substance rules? Which states allow it? And is telehealth treatment safe and effective?
This comprehensive guide answers all your questions about accessing BED medication via telehealth in 2025–2026, including the latest federal and state regulations, which medications are available, who can prescribe them, and what to expect during your virtual care journey.
Binge Eating Disorder is a serious mental health condition characterized by recurrent episodes of eating large quantities of food in a short period (usually within two hours), accompanied by a sense of loss of control. According to DSM-5 criteria, a BED diagnosis requires:
BED affects approximately 2.8 million Americans and is the most common eating disorder in the United States. Unlike anorexia or bulimia, BED often goes undiagnosed because many people don’t realize it’s a treatable medical condition.
Evidence-based treatment for BED typically includes:
Psychotherapy: Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and Interpersonal Therapy have shown significant effectiveness in reducing binge episodes.
Nutritional Counseling: Working with registered dietitians to establish regular eating patterns and develop a healthier relationship with food.
Medication: While only one medication (lisdexamfetamine/Vyvanse) has FDA approval specifically for BED, several other medications are commonly prescribed off-label with clinical evidence supporting their use.
Comprehensive Care: The most effective approach often combines multiple treatment modalities tailored to individual needs.
For non-controlled medications commonly used to treat Binge Eating Disorder—including Topamax (topiramate) and Wellbutrin (bupropion)—telehealth providers can legally prescribe them in every state, as long as they’re licensed in your state and follow standard medical practices.
Here’s why this works:
These medications are not controlled substances, meaning the strict federal in-person requirements under the Ryan Haight Act do not apply. The Ryan Haight Act only restricts telemedicine prescribing of controlled medications (Schedule II–V drugs like stimulants, opioids, and benzodiazepines). Non-controlled prescription medications have never been subject to these federal telehealth restrictions.
Current DEA policy extensions—most recently extended through December 31, 2026—focus on controlled substance prescribing flexibilities. For BED treatments using non-controlled medications, telehealth access remains fully open with no additional federal barriers.
During the COVID-19 pandemic, nearly all states adopted emergency telehealth flexibilities. The good news? Most states have now made these changes permanent or incorporated them into standard medical practice regulations.
As of 2025–2026:
It’s important to understand that only one medication is FDA-approved specifically for BED: lisdexamfetamine (Vyvanse), which is a Schedule II controlled substance. Due to stricter DEA regulations on controlled medications, most telehealth platforms do not prescribe Vyvanse for BED.
However, several non-controlled medications have clinical evidence supporting their use in treating BED and are commonly prescribed off-label:
Schedule Status: Non-controlled (legend drug)
Primary FDA Approvals: Seizure disorders, migraine prevention
BED Use: Off-label for impulse control and reducing binge frequency
How It Works for BED:
Topiramate affects neurotransmitters in the brain that may influence eating behaviors and impulse control. Clinical studies have shown it can help reduce binge eating episodes and may lead to modest weight loss in some patients.
Telehealth Availability: ✅ Fully available via telehealth nationwide
Key Considerations:
Typical Telehealth Protocol:
90-day supply commonly prescribed with refills; initial low-dose start with regular follow-up visits to monitor tolerability and adjust dosing.
Schedule Status: Non-controlled (legend drug)
Primary FDA Approvals: Depression, seasonal affective disorder, smoking cessation
BED Use: Off-label for reducing binge frequency and addressing co-occurring depression
How It Works for BED:
Bupropion is an atypical antidepressant that affects dopamine and norepinephrine. Research suggests it may help reduce binge eating episodes, particularly in patients with co-occurring depression or who need support with weight management.
Telehealth Availability: ✅ Fully available via telehealth nationwide
Key Considerations:
Typical Telehealth Protocol:
Up to 90-day supply with refills; started at lower dose and increased gradually; regular mood and side-effect monitoring during follow-up visits.
Many patients worry when they learn their medication is being prescribed ‘off-label.’ This is actually extremely common and completely legal in medicine. Off-label prescribing means using an FDA-approved medication for a condition other than what it was originally approved to treat.
Key points about off-label use:
For BED specifically, off-label prescribing is the norm because Vyvanse (the only FDA-approved option) is a controlled substance with more restrictive prescribing rules.
While federal law permits telehealth prescribing of non-controlled medications, individual states set additional requirements for medical practice within their borders. Here’s what varies by state:
States with no mandatory in-person requirement for non-controlled medications include:
In these states, your entire BED treatment—from initial evaluation through ongoing medication management—can occur via telehealth without ever requiring a physical office visit.
A few states require periodic in-person visits for ongoing telehealth treatment:
Alabama: After 4 telehealth visits within 12 months for the same condition, an in-person visit must occur within one year. This can be satisfied by seeing any healthcare provider (including a collaborating provider at a local clinic), not necessarily your telehealth prescriber.
Georgia: Must attempt an in-person exam at least annually for ongoing telemedicine care. Initial evaluation via telehealth is explicitly allowed if equivalent to in-person examination.
New Hampshire: For controlled substances (not relevant for Topamax/Wellbutrin), requires an in-person follow-up within 12 months. Non-controlled medications have no such requirement.
Important: Even in these states, you can start treatment entirely via telehealth. The in-person requirement only applies to long-term, ongoing care—and legitimate telehealth services can help coordinate local follow-up visits if needed.
New York (2025 Update): While NY adopted rules requiring in-person exams before prescribing controlled substances (effective when federal waivers end), these rules do not apply to non-controlled BED medications like Topamax or Wellbutrin.
California (2025 Update): AB 1503 clarified that ‘good faith prior examination’ can include asynchronous telehealth (like detailed online questionnaires), expanding access even further.
New Hampshire (August 2025): SB 252 explicitly modernized telehealth rules to allow even Schedule II–IV prescribing via telemedicine (with annual in-person follow-up), signaling the state’s strong support for telehealth access.
All physicians licensed in your state can prescribe these medications via telehealth, whether they’re psychiatrists, family medicine doctors, or other specialists.
The landscape for Nurse Practitioner prescribing authority has changed dramatically in recent years. As of 2025:
34 states (plus Washington DC) grant Full Practice Authority (FPA) to Nurse Practitioners, meaning they can:
Recent additions to FPA states (2023–2025):
States still requiring physician collaboration include:
What ‘Collaboration’ Means for You:
In collaborative states, your NP must have a formal agreement with a supervising physician. This is a behind-the-scenes regulatory requirement—it usually doesn’t affect your care experience. You may see both the NP’s and physician’s names on your prescription, but the NP is still the primary provider managing your treatment.
Bottom Line: In every state, licensed NPs working through legitimate telehealth platforms can prescribe Topamax and Wellbutrin for BED, either independently or under collaborative agreements.
PAs can also prescribe these non-controlled medications in all states, though they typically work under supervising physician agreements similar to NPs in collaborative states.
Reputable telehealth providers conduct thorough evaluations that mirror in-person standards of care. Here’s what a typical first appointment includes:
1. Identity and Location Verification (5 minutes)
The provider will confirm your identity and physical location. This isn’t invasive—it’s required by many state laws to ensure the provider is licensed in your state and to prevent fraud.
2. Comprehensive Medical History (15–20 minutes)
Expect detailed questions about:
3. BED Diagnostic Screening (10–15 minutes)
Your provider will assess whether you meet DSM-5 criteria for Binge Eating Disorder:
Some providers use standardized questionnaires like:
4. Treatment Discussion and Informed Consent (10–15 minutes)
If medication is appropriate, your provider will:
Total Initial Visit Time: Expect 45–60 minutes for a comprehensive evaluation. If a service only asks a few questions and issues a prescription in 5–10 minutes, that’s a red flag.
Safety is paramount. Telehealth providers will screen for conditions that require in-person evaluation or make certain medications inappropriate:
Absolute Contraindications for Bupropion (Wellbutrin):
High-Risk Situations Requiring In-Person Evaluation:
When Telehealth Providers Will Refer You:Legitimate platforms will refer you to in-person specialists when:
This is actually a good sign—it shows the platform prioritizes safety over revenue.
Many patients wonder: ‘Will my doctor look up my prescription history?’
The Legal Reality:
Most states require prescribers to check the state Prescription Monitoring Program (PMP) database before prescribing controlled substances (opioids, stimulants, benzodiazepines). However, because Topamax and Wellbutrin are not controlled substances, these mandatory PMP check laws typically do not apply.
Best Practice Reality:
Even when not legally required, many telehealth providers will:
This is simply good medical practice, not surveillance. It helps your provider keep you safe.
What Shows Up in a PMP:
PMPs track controlled substance prescriptions. Your Topamax or Wellbutrin prescription may or may not appear, depending on how your state’s system is configured. Generally, only controlled medications (Schedule II–V) are consistently tracked.
Your Privacy Is Protected:
PMP data is confidential medical information. Access is restricted to:
Checking the PMP is not a judgment—it’s a safety tool to prevent dangerous drug combinations and interactions.
The rapid expansion of telehealth during COVID-19 brought both innovation and problems. Some platforms prioritized profit over patient safety, leading to regulatory crackdowns (like the 2024 indictment of Done Global executives for allegedly running an online ‘pill mill’ for ADHD stimulants).
✅ Comprehensive Initial Evaluation
✅ Licensed Providers
✅ Transparent Prescribing Policies
✅ Regular Follow-Up Schedule
✅ Multi-Disciplinary Approach
✅ Professional Pharmacy Coordination
✅ Privacy and Security
🚩 Prescription Promises Before Evaluation
‘Guaranteed medication’ or ‘Get your prescription today’ marketing before you’ve been assessed
🚩 Minimal Screening
Brief questionnaires (5–10 minutes) leading directly to prescriptions
🚩 No Discussion of Alternatives
Pushing medication without mentioning therapy, nutrition, or other approaches
🚩 Direct Medication Sales
Shipping pills from the company itself rather than using pharmacies
🚩 Pressure Tactics
Urgency to commit, subscribe, or pay before speaking with a provider
🚩 No Follow-Up Required
Prescriptions without scheduled follow-up appointments
🚩 Too-Good-To-Be-True Pricing
Extremely low costs that seem unrealistic (may indicate low-quality care)
🚩 Unclear Provider Credentials
Can’t verify who your provider is or where they’re licensed
At Klarity Health, we’ve built our telehealth platform specifically to address the quality and safety concerns that have plagued some online providers:
Provider Availability: We maintain a network of licensed psychiatrists, psychiatric nurse practitioners, and other mental health specialists across multiple states, ensuring you can connect with a qualified provider quickly—often within 24–48 hours.
Transparent Pricing: Our cash-pay rates are clearly displayed upfront, with no hidden fees or surprise charges. For those with insurance, we accept most major plans and provide transparent information about coverage and out-of-pocket costs.
Dual Payment Options: Whether you prefer to use insurance or pay out-of-pocket, we’ve designed our platform to accommodate both, giving you flexibility and control over your healthcare spending.
Comprehensive Evaluations: Our providers conduct thorough initial assessments (45–60 minutes) that meet or exceed traditional in-person standards, ensuring medication is appropriate and safe for your individual situation.
Evidence-Based Treatment: We emphasize the combination of medication management with therapeutic approaches, connecting patients with resources for CBT, DBT, nutrition counseling, and support groups.
Week 1–2: Starting Low
Most providers start Topamax or Wellbutrin at lower doses to assess tolerability. For example:
Week 2–4: First Follow-Up
Your provider will check in to assess:
Weeks 4–12: Titration Phase
Doses may be gradually increased based on your response:
Month 3+: Maintenance
Once you’ve reached an effective dose with tolerable side effects, you’ll transition to:
Because these are non-controlled medications, your provider can typically authorize:
However, expect regular follow-up appointments:
Some states (Alabama, Georgia, New Hampshire) may require periodic in-person visits for long-term telehealth care—your provider will help coordinate these if needed.
Your provider will track multiple outcomes:
Treatment is successful when binge frequency decreases significantly and you develop healthier coping mechanisms—not just when you lose weight.
Reasons to Adjust Treatment:
Discontinuation:
If you and your provider decide to stop medication:
Good News: Most insurance plans now cover telehealth at the same level as in-person visits, thanks to permanent changes made during the pandemic.
Mental Health Parity:
Federal law requires insurance plans to cover mental health conditions (including eating disorders) at the same level as physical health conditions. This means:
Verify Your Coverage:
For those without insurance or who prefer not to use it:
Typical Telehealth Visit Costs:
Medication Costs:
At Klarity Health:
We offer transparent cash-pay pricing with no surprise bills, and we also work with most insurance plans to help you maximize your benefits. Our platform shows you the cost upfront, whether you’re using insurance or paying out-of-pocket.
If cost is a barrier:
While medication can be helpful, research consistently shows that comprehensive, multi-faceted treatment produces the best outcomes for Binge Eating Disorder.
Cognitive Behavioral Therapy (CBT):
The most researched therapy for BED, CBT helps you:
Dialectical Behavior Therapy (DBT):
Particularly helpful for emotional regulation, DBT teaches:
Interpersonal Therapy (IPT):
Focuses on relationships and life transitions that may contribute to binge eating.
Availability via Telehealth:
Many therapists now offer virtual CBT, DBT, and IPT specifically for eating disorders. Your medication provider may be able to refer you to teletherapy options.
Registered Dietitians (RDs) specializing in eating disorders can help:
Many RDs now offer telehealth nutrition counseling.
Medication addresses neurobiological aspects of BED (impulse control, mood), while therapy and nutrition counseling address:
Most clinical guidelines recommend medication as one component of comprehensive treatment, not as standalone therapy.
December 2025 Update:
The DEA extended COVID-era telehealth prescribing flexibilities for controlled substances through December 31, 2026. This is the fourth extension.
What This Means:
Looking Ahead:
The DEA is expected to issue permanent telehealth rules by end of 2026. While these will primarily affect controlled substance prescribing, the overall trend supports expanded telehealth access with appropriate safeguards.
New Hampshire (August 2025):
SB 252 modernized telehealth law to explicitly allow Schedule II–IV prescribing via telemedicine (with annual in-person follow-up), removing previous barriers.
Wisconsin (August 2025):
The APRN Modernization Act granted full practice authority to Nurse Practitioners, allowing independent prescribing—including via telehealth.
Michigan (2025):
Public Act 47 of 2023’s provisions fully implemented, establishing NP full practice authority.
New York (May 2025):
Final rule adopted requiring in-person exams before prescribing controlled substances (with limited exceptions), but explicitly exempting non-controlled medications.
California (2025):
AB 1503 further clarified that asynchronous telehealth can satisfy prior examination requirements, expanding access.
Alabama and South Carolina:
Both states have discussed legislation to grant Nurse Practitioners full practice authority, but as of late 2025, these bills have not passed. NPs in these states still require physician collaboration.
DEA Permanent Rules:
The proposed ‘special registration’ system for telehealth controlled substance prescribing (announced March 2023) remains in limbo. Monitor for updates through 2026.
The regulatory environment continues to support and expand telehealth access for mental health treatment, including eating disorders. While some rules around controlled substances remain in flux, access to non-controlled BED medications via telehealth is stable and well-established across all 50 states.
Q: Do I need to have an in-person visit before getting BED medication via telehealth?
A: In most states, no. The majority of states allow your initial evaluation and all follow-up care to occur entirely via telehealth for non-controlled medications like Topamax and Wellbutrin. A few states (Alabama, Georgia) require periodic in-person visits for long-term care, but you can still start treatment online.
Q: Will my telehealth provider have access to my prescription history?
A: Your provider may check the state Prescription Monitoring Program as part of comprehensive care, but this is not legally required for non-controlled medications. They will ask about your current medications to check for interactions and ensure safe prescribing.
Q: Can Nurse Practitioners prescribe BED medication, or do I need to see a doctor?
A: In all 50 states, licensed Nurse Practitioners can prescribe Topamax and Wellbutrin for BED. In states with Full Practice Authority (34 states + DC), they can do so independently. In other states, they work under collaborative agreements with physicians, which doesn’t typically affect your care experience.
Q: Is it safe to get eating disorder treatment entirely online?
A: Yes, when done properly. Legitimate telehealth providers conduct comprehensive evaluations equivalent to in-person visits and follow evidence-based treatment protocols. However, some conditions require in-person evaluation—providers should screen for these and refer when appropriate.
Q: Will my insurance cover telehealth for BED?
A: Most insurance plans now cover telehealth mental health visits at the same level as in-person care, thanks to permanent policy changes. Check your specific plan’s coverage, and verify whether your provider is in-network.
Q: How long does it take to see results from BED medication?
A: Most patients begin noticing some reduction in binge frequency within 4–8 weeks of reaching a therapeutic dose. Full benefits may take 2–3 months. Medication works best when combined with therapy and nutrition counseling.
Q: What if the medication doesn’t work or I have side effects?
A: Your provider will work with you to adjust doses, try alternative medications, or modify your treatment plan. Regular follow-up appointments are specifically designed to monitor your response and make changes as needed.
Q: Can I get a prescription for Vyvanse (the FDA-approved BED medication) via telehealth?
A: This is more complicated because Vyvanse is a controlled substance (Schedule II stimulant). Most telehealth platforms do not prescribe controlled stimulants due to stricter regulations and safety concerns. If Vyvanse is deemed necessary, you’ll typically need an in-person evaluation with a specialist.
Q: Are these medications safe during pregnancy?
A: No—particularly topiramate, which carries significant risk of birth defects. Both medications should generally be avoided during pregnancy and breastfeeding. If you become pregnant while taking these medications, contact your provider immediately. Women of childbearing potential should use effective contraception.
Q: How do I know if a telehealth provider is legitimate and not a ‘pill mill’?
A: Look for: comprehensive initial evaluations (30+ minutes), discussion of multiple treatment options, licensed providers with verifiable credentials, regular follow-up requirements, use of standard pharmacies, and transparent policies. Avoid providers that promise prescriptions before evaluation or skip detailed medical history.
Consider these options:
Find the right provider for your needs — select your state to find expert care near you.